Singapore markets closed

Verve Therapeutics, Inc. (VERV)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.00-0.01 (-0.17%)
At close: 04:00PM EDT
6.00 0.00 (0.00%)
After hours: 07:25PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
11,758
11,758
1,941
0
0
Operating expenses
Research development
184,946
184,946
130,095
68,202
35,371
Selling general and administrative
49,936
49,936
37,533
18,865
5,256
Total operating expenses
234,882
234,882
167,628
87,067
40,627
Operating income or loss
-223,124
-223,124
-165,687
-87,067
-40,627
Total other income/expenses net
165
165
1,486
-33,389
-5,239
Income before tax
-199,793
-199,793
-157,334
-120,314
-45,704
Income tax expense
275
275
53
0
0
Income from continuing operations
-200,068
-200,068
-157,387
-120,314
-45,704
Net income
-200,068
-200,068
-157,387
-120,314
-45,704
Net income available to common shareholders
-200,068
-200,068
-157,387
-120,314
-45,704
Basic EPS
-3.08
-
-2.91
-4.48
-2.58
Diluted EPS
-3.08
-
-2.91
-4.48
-2.58
Basic average shares
62,129
-
54,024
26,872
17,739
Diluted average shares
63,737
-
54,024
26,872
17,739